Company Filing History:
1 out of 2 
1 out of 1,325 
Years Active: 2025
Title: The Innovative Contributions of Robert Tigelaar
Introduction
Robert Tigelaar is a notable inventor based in New Haven, Connecticut. He has made significant contributions to the field of immunology, particularly in the development of methods for producing immuno-stimulatory autologous dendritic cells. His work has implications for treating patients suffering from hyper-proliferative diseases such as cancer.
Latest Patents
Robert Tigelaar holds a patent for a "Method for obtaining globally activated monocytes." This invention relates to innovative methods for producing dendritic cells that can stimulate the immune system, offering potential therapeutic benefits for cancer patients.
Career Highlights
Throughout his career, Robert has worked with prominent organizations, including Transimmune AG and Yale University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Robert has collaborated with esteemed colleagues such as Günter Bauer and Justin Duckworth. These partnerships have further enriched his research endeavors and expanded the impact of his work.
Conclusion
Robert Tigelaar's innovative contributions to immunology and his dedication to advancing cancer treatment through his patented methods highlight his importance in the field. His work continues to inspire future research and development in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.